Apyx Medical Corporation Reports First Quarter 2025 Financial ResultsBy ApyxMedical|2025-12-12T17:52:13+00:00May 8, 2025|2025 Shareholder News, J-Plasma, Renuvion|
Renuvion Introduces Television Star Dolores Catania as Chief of ConfidenceBy ApyxMedical|2025-12-18T14:07:36+00:00May 1, 2025|2025 Shareholder News, Renuvion|
Apyx Medical Corporation Announces Two Peer-reviewed Publications On The Use Of Renuvion In Abdominal Body Contouring ProceduresBy ApyxMedical|2025-12-12T17:53:09+00:00April 29, 2025|2025 Shareholder News, Renuvion|
Apyx Medical Corporation To Release First Quarter Of Fiscal Year 2025 Financial Results On May 8, 2025By ApyxMedical|2025-12-12T17:53:35+00:00April 24, 2025|2025 Shareholder News, J-Plasma, Renuvion|
Renuvion Wins 2025 Newbeauty Award For “best Minimally Invasive Skin Tightener”By ApyxMedical|2025-12-12T17:54:03+00:00March 25, 2025|2020 Shareholder News, 2025 Shareholder News, Renuvion|
Apyx Medical Corporation Reports Fourth Quarter And Full Year 2024 Financial ResultsBy ApyxMedical|2025-12-12T17:54:32+00:00March 13, 2025|2024 Shareholder News, 2025 Shareholder News, J-Plasma, Renuvion|
APYX MEDICAL CORPORATION TO RELEASE FOURTH QUARTER AND FISCAL YEAR 2024 FINANCIAL RESULTS ON MARCH 13, 2025By ApyxMedical|2025-12-12T17:55:01+00:00February 28, 2025|2024 Shareholder News, 2025 Shareholder News, J-Plasma, Renuvion|
APYX MEDICAL CORPORATION REPORTS PRELIMINARY FOURTH QUARTER AND FULL YEAR 2024 REVENUE RESULTSBy ApyxMedical|2025-12-12T17:55:32+00:00January 13, 2025|2024 Shareholder News, 2025 Shareholder News, J-Plasma, Renuvion|
APYX MEDICAL CORPORATION SUBMITS 510(K) PREMARKET NOTIFICATION TO THE U.S. FOOD AND DRUG ADMINISTRATION FOR THE AYON BODY CONTOURING SYSTEM™By ApyxMedical|2025-12-12T17:55:58+00:00January 6, 2025|2024 Shareholder News, Renuvion|
APYX MEDICAL CORPORATION TO PARTICIPATE IN THE PIPER SANDLER 36TH ANNUAL HEALTHCARE CONFERENCEBy ApyxMedical|2025-12-12T17:56:25+00:00December 2, 2024|2024 Shareholder News, Renuvion|
APYX MEDICAL CORPORATION ANNOUNCES $7,000,000 MILLION REGISTERED DIRECT OFFERINGBy ApyxMedical|2025-12-12T17:56:54+00:00November 8, 2024|2024 Shareholder News, J-Plasma, Renuvion|
Apyx Medical Corporation Reports Third Quarter 2024 Financial Results; Updates Full Year 2024 Financial Outlook and Introduces Full Year 2025 Financial OutlookBy ApyxMedical|2025-12-12T17:57:22+00:00November 7, 2024|2024 Shareholder News, J-Plasma, Renuvion|
APYX MEDICAL CORPORATION TO RELEASE THIRD QUARTER OF FISCAL YEAR 2024 FINANCIAL RESULTS ON NOVEMBER 8, 2024By ApyxMedical|2025-12-12T17:57:48+00:00October 24, 2024|2024 Shareholder News, J-Plasma, Renuvion|
RENUVION NAMED #1 TRUSTED BODY CONTOURING TECHNOLOGY BY DOCTORS*By ApyxMedical|2025-12-12T17:58:14+00:00August 13, 2024|2024 Shareholder News, Renuvion|
APYX MEDICAL CORPORATION ANNOUNCES PEER-REVIEWED CLINICAL PUBLICATION COMPARING THE USE OF RENUVION TO A COMPETING TECHNOLOGY FOLLOWING LIPOSUCTION OR BODY CONTOURING PROCEDURESBy ApyxMedical|2025-12-12T17:58:38+00:00August 8, 2024|2024 Shareholder News, J-Plasma, Renuvion|
APYX MEDICAL CORPORATION REPORTS SECOND QUARTER 2024 FINANCIAL RESULTS; UPDATES FULL YEAR 2024 FINANCIAL OUTLOOKBy ApyxMedical|2025-12-12T17:59:34+00:00August 8, 2024|2024 Shareholder News, J-Plasma, Renuvion|
